Watson Recalls Lutera Tablets Due to Potential Hydrochlorothiazide Contamination
Watson Laboratories is recalling specific lots of Lutera tablets because they may contain trace amounts of Hydrochlorothiazide (HCTZ).
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves potential trace contamination with an unrelated medication (HCTZ) without reported illnesses or injuries, fitting the criteria for a moderate severity precautionary recall.
Plain-English summary
Watson Laboratories, Inc. is recalling specific lots of Lutera (levonorgestrel and ethinyl estradiol) Tablets USP. The recall involves 67,860 cartons of the medication, which are packaged as 28-count tablets per dispenser with 6 dispensers per carton. The affected lots were distributed nationwide and in Puerto Rico.
The recall was initiated because certain lots of Lutera, along with related products Zovia, Necon, and Zenchent, could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ) due to cross-contamination with other products. The specific lot numbers affected are 517921AA, 517921AB, 517922AA, 517922AB, 517923AA, and 517923AB, all with an expiration date of 03/31/14.
Consumers and healthcare providers should check their medication packaging for these specific lot numbers. If the medication matches the recalled description, they should stop using it and contact their healthcare provider or pharmacist for guidance on next steps.
The recalled product
- Product
- Lutera (levonorgestrel and ethinyl estradiol) Tablets USP, 0.1 mg/0.02 mg, inert tablets, 28-count tablets per dispenser packaged in 6 Tablet Dispensers per carton, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880 USA; Distributed by: Watson Pharma, Inc.…
- Manufacturer
- Watson Laboratories Inc
- Category
- Drug — Oral Contraceptive
- Affected units
- 67,860
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Lot #: 517921AA
- 517921AB
- 517922AA
- 517922AB
- 517923AA
- 517923AB
- Exp 03/31/14
Distribution
Part of a larger recall action
This product is one of 5 recalled by Watson Laboratories Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Watson Laboratories Inc
See all →- ModerateWatson Recalls Hydrocodone and Acetaminophen Tablets Due to Broken Tablets
FDA (Drugs) · 2014-02-05
- SevereWatson Recalls Carisoprodol Tablets Due to Metal Particulates
FDA (Drugs) · 2014-01-15
- ModerateWatson Recalls Next Choice Emergency Contraceptive Tablets Due to Breakage
FDA (Drugs) · 2013-10-16
- SevereWatson Recalls Oxycodone and Acetaminophen Tablets Due to Foreign Contamination
FDA (Drugs) · 2013-10-09
- LowWatson Recalls Hydrocodone and Acetaminophen Tablets Due to Defective Seals
FDA (Drugs) · 2013-09-25
Same hazard · cross contamination
See all →- HighFDA Recalls Performance Pro Nitrile Gloves Due to Defects
FDA (Devices) · 2026-10-07
- HighFDA Recalls Defective Blue Nitrile Patient Examination Gloves
FDA (Devices) · 2026-10-07
- HighFDA Recalls Opportunity Pro Nitrile Gloves Due to Manufacturing Defects
FDA (Devices) · 2026-10-07
- ModerateSage Products Recalls Chlorhexidine Gluconate Cloth Due to Cross Contamination
FDA (Drugs) · 2026-09-09
- CriticalCetirizine Hydrochloride Tablets Recalled Due to Cross Contamination with Ranitidine
FDA (Drugs) · 2026-07-29
Similar recalls
- LowActavis Recalls Lutera Birth Control Due to Outdated Package Inserts
FDA (Drugs) · 2015-07-01
- SevereWatson Recalls Hydrocodone and Acetaminophen Tablets Due to Superpotent Risk
FDA (Drugs) · 2012-11-28
- LowWatson Recalls Caziant Tablets Due to Out-of-Specification Impurities
FDA (Drugs) · 2012-12-26
- ModerateWatson Recalls Caziant Tablets Due to High Impurity Levels
FDA (Drugs) · 2012-08-08
- SevereTorrent Pharma Recalls Losartan Potassium and Hydrochlorothiazide Tablets
FDA (Drugs) · 2019-10-09
- ModerateWatson Recalls Hydrocodone and Acetaminophen Tablets Due to Broken Tablets
FDA (Drugs) · 2014-02-05